Image:
Colossal Biosciences CEO Ben Lamm | Credit: Colossal Biosciences
Ben Lamm's firm has raised $225m of investment to bring back the woolly mammoth, dodo, and Tasmanian tiger - he talks to BusinessGreen about his bold vision for nature conservation
Ben Lamm wants to get one thing straight about his Spielberg-esque biotechnology company. "Colossal isn't working on bringing back dinosaurs," he tells BusinessGreen. "It's impossible to de-extinct a dinosaur."...
To continue reading this article...
Join BusinessGreen
- Enjoy exclusive news, insights and analysis from Europe’s leading source of information on the green economy and business.
- Make smart, responsible business decisions with an eye on the latest regulatory and tech development
- Tap into our extensive archive of exclusive articles, news, analysis and guide
- Access to our new BusinessGreen intelligence service, providing you with
- > Exclusive in-depth case studies
- > Policy briefings, white papers and reports on market trends that are shaping the direction of the net zero transition
- > Our overnight briefing, expertly curated help you run a competitive and sustainable business
- > Online and interactive meetings with BusinessGreen’s editors to discuss the crucial stories and trends from the past month
Choose the membership package that's right for you and your organisation, via our 3 membership levels.
